Therapeutics News and Research

RSS

CBPR approach aims to educate diverse patients with rheumatic conditions

At the 2019 American College of Rheumatology/Association of Rheumatology Professionals annual meeting in Atlanta, experts from the HSS Education Institute at Hospital for Special Surgery presented their method for developing and implementing effective educational programs for diverse patients with rheumatic conditions.

11 Nov 2019

Study provides new insight into antibiotic synthesis

Researchers at McGill University's Faculty of Medicine have made important strides in understanding the functioning of enzymes that play an integral role in the production of antibiotics and other therapeutics. Their findings are published in Science.

11 Nov 2019

Retinal hyperspectral imaging shows promise for early Alzheimer's disease detection

Alzheimer's disease is the leading cause of dementia in the U.S., with approximately 5.4 million currently affected and an estimated 16 million by 2050.

11 Nov 2019

Male patients with lupus often have more severe disease, receive little support

A national survey of male patients with lupus finds the illness has a significant impact on their physical and emotional health, yet they often do not receive support that could help them cope.

11 Nov 2019

Preclinical data on new drug combination to treat neuroblastoma published

Neuroblastoma is the most common cancer outside of the brain in infants and young children and often fails to respond to therapy. Though it can appear in several areas of the body, it commonly develops as a solid tumor most frequently found in or adjacent to the adrenal glands, which sit atop the kidneys.

10 Nov 2019

Investigators use the power of computation to build better targeted drug therapy

Antibody drug conjugates (ADCs) -- cancer drugs that are designed to target and destroy cancerous tissue while leaving healthy cells intact -- represent a long sought-after advancement in cancer therapy.

8 Nov 2019

Fight for Sight-funded research identifies potential alternative to treat corneal infections, sight loss

A researcher from the University of Nottingham has discovered a possible alternative to traditional anitbiotics to treat corneal infections.

8 Nov 2019

Study: Regular exercise reduces cholesterol, protects the cardiovascular system

Regular exercise protects the cardiovascular system by reducing risk factors such as cholesterol and blood pressure. "But we believe there are certain risk factors for cardiovascular disease that are not fully understood," says Matthias Nahrendorf, MD, PhD, of the Center for Systems Biology at MGH.

7 Nov 2019

Dundee researchers find way to better understand neurological diseases

A University of Dundee discovery has the potential to help scientists better understand neurological diseases such as Alzheimer's and Parkinson's.

7 Nov 2019

Researchers make new discovery about how exercise protects against cardiovascular disease

A study has identified a molecular link between exercise and inflammation that help to treat cardiovascular disease.

7 Nov 2019

MD Anderson, Artios Pharma and ShangPharma collaborate for ATR inhibitor program

The University of Texas MD Anderson Cancer Center, Artios Pharma Limited and ShangPharma Innovation today announce the in-licensing by Artios of a small-molecule ATR inhibitor program, developed jointly by MD Anderson and ShangPharma.

6 Nov 2019

Nanotechnologies can lead to big advances in cancer therapy

Nami Therapeutics Corporation, which gets its name from the Mandarin word for "nano," is committed to using nanotechnologies to make big advances in cancer therapy.

6 Nov 2019

Study characterizes MRI patterns of acute surfing-related injuries

Over the last few years, surfing has increased in popularity, with about 2.6 million recreational surfers in the United States. Efforts are under way to include competitive surfing in the Olympics.

6 Nov 2019

Reports on surfing-related injuries do not reflect the trend in popularity, shows study

Over the last few years, surfing has increased in popularity, with about 2.6 million recreational surfers in the United States.

6 Nov 2019

Study: Pleural effusions are linked with NSCLC and malignant mesothelioma

Cryopreserved cell-free PE fluid from 101 NSCLC patients, 8 mesothelioma and 13 with benign PE was assayed for a panel of 40 cytokines/chemokines using the Luminex system.

6 Nov 2019

UM launches CAR-T clinical trial for patients with myasthenia gravis

Neuromuscular experts with the University of Miami Health System and the Miller School of Medicine will launch a Phase 1/2 clinical trial (NCT04146051) using the CAR-T drug, Descartes-08, to treat patients with generalized myasthenia gravis.

5 Nov 2019

Head impacts, not age, determine brain's white matter changes in football players

Magnetic resonance imaging scans performed at the beginning and end of football season show significant changes in the brain's white matter in both youth and high school football players, reports a study in Clinical Journal of Sport Medicine.

5 Nov 2019

MD Anderson and Takeda announce agreement to develop off-the-shelf CAR NK-cell therapy platform

The University of Texas MD Anderson Cancer Center and Takeda Pharmaceutical Company Limited today announced an exclusive license agreement and research agreement to develop cord blood-derived chimeric antigen receptor-directed natural killer (CAR NK)-cell therapies, 'armored' with IL-15, for the treatment of B-cell malignancies and other cancers.

5 Nov 2019

ISPOR explores digital health technologies to address key health-related challenges

ISPOR, the professional society for health economics and outcomes research - explored the potential of digital health technologies to address key health-related challenges and how to best evaluate these technologies as the field evolves.

5 Nov 2019

Protein may help predict, prevent and treat brain metastases

A protein that breast, lung and other cancers use to promote their spread--or metastasis--to the brain, has been identified by a team led by Weill Cornell Medicine and New York-Presbyterian investigators. The protein, CEMIP, will now be a focus of efforts to predict, prevent and treat brain metastases, which are a frequent cause of cancer deaths.

4 Nov 2019

Therapeutics News and Research

CBPR approach aims to educate diverse patients with rheumatic conditions

Study provides new insight into antibiotic synthesis

Retinal hyperspectral imaging shows promise for early Alzheimer's disease detection

Male patients with lupus often have more severe disease, receive little support

Preclinical data on new drug combination to treat neuroblastoma published

Investigators use the power of computation to build better targeted drug therapy

Fight for Sight-funded research identifies potential alternative to treat corneal infections, sight loss

Study: Regular exercise reduces cholesterol, protects the cardiovascular system

Dundee researchers find way to better understand neurological diseases

Researchers make new discovery about how exercise protects against cardiovascular disease

MD Anderson, Artios Pharma and ShangPharma collaborate for ATR inhibitor program

Nanotechnologies can lead to big advances in cancer therapy

Study characterizes MRI patterns of acute surfing-related injuries

Reports on surfing-related injuries do not reflect the trend in popularity, shows study

Study: Pleural effusions are linked with NSCLC and malignant mesothelioma

UM launches CAR-T clinical trial for patients with myasthenia gravis

Head impacts, not age, determine brain's white matter changes in football players

MD Anderson and Takeda announce agreement to develop off-the-shelf CAR NK-cell therapy platform

ISPOR explores digital health technologies to address key health-related challenges

Protein may help predict, prevent and treat brain metastases

Understanding the DNA Damage Response in Innate Immunity eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News